PD-1 and CTLA-4 inhibitors in combination vs. alone for the treatment of advanced melanoma: A systematic review and meta-analysis

Metastatic melanoma treatment has drastically changed during the past decade with the advent of immunotherapy. We conducted a meta-analysis, to assess PD-1 and CTLA-4 inhibitors in combination vs. alone for the treatment of advanced melanoma. METHODS: The EMBASE, Medline via PubMed, Scopus, Cochrane...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Runzhi, Zhao, Xiaoling, Liu, Jianmin, Zhou, Yajing, Zhang, Xiaochong, Cheng, Fang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
4000
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9575742/
https://www.ncbi.nlm.nih.gov/pubmed/36254050
http://dx.doi.org/10.1097/MD.0000000000030561

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9575742/
https://www.ncbi.nlm.nih.gov/pubmed/36254050
http://dx.doi.org/10.1097/MD.0000000000030561

Ejemplares similares